Views & Analysis Exclusive live coverage: Frontiers Health 2017 What does the cutting-edge of digital health look like? Which innovations are on the cusp of becoming a mainstream reality and who is it that is driving this advancement?
Views & Analysis Nanomedicine: delivering on its promise? The nanomedicines market is worth billions. Tarun Pandotra reviews developments in the sector.
Partner Content Partner Content How Doctors’ Conversations Differ From Private to Public Soc... ocial Media in Pharma
Views & Analysis Keep it simple, scientists: AZ’s productivity push regains 1... AZ time management challenge has saved more than two million hours across the global company.
Partner Content Partner Content Partnership Opportunities in Drug Delivery (PODD) 2017 Oct 19-20, 2017 at the Marriott Copley Place in Boston
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.